Progenics Pharmaceuticals Inc. (PGNX)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 8.45
   
  • Change Today:
    $0.34
  • 52 Week High: $11.18
  • 52 Week Low: $4.58
  • Currency: US Dollars
  • Shares Issued: 33.86m
  • Volume: 148,992
  • Market Cap: $286.13m
  • RiskGrade: 256
  • Beta: 1.89

Latest ShareCast News

PGNX ShareCast News

No recent information was found.

PGNX Newspaper Links

No recent information was found.

PGNX Tips & Analysis

Profit from pain 06-Mar-2006 BayArea.com

PGNX News Wires

No recent information was found.

Other PGNX News

BioMed Realty Trust Extends Lease at Landmark Wi... 29-Oct-2009 PR Newswire
New England Journal of Medicine Publishes Result... 28-May-2008 PR Newswire
Wyeth and Progenics Announce Preliminary Clinica... 22-May-2008 PR Newswire
Wyeth and Progenics Receive Positive Opinion Fro... 24-Apr-2008 PR Newswire
Monogram Biosciences Provides Progenics Pharmace... 01-Apr-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

PGNX Market Data

Currency US Dollars
Share Price $ 8.45
Change Today $ 0.34
% Change 4.19 %
52 Week High $11.18
52 Week Low $4.58
Volume 148,992
Shares Issued 33.86m
Market Cap $286.13m
Beta 1.89
RiskGrade 256

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:00 6,777 @ $8.45
15:59 200 @ $8.47
15:59 119 @ $8.46
15:59 119 @ $8.46
15:59 119 @ $8.46

Top of Page